Pamir Ozan bought NAGE
November 14, 2025 · Form 4 insider transaction
Pamir Ozan bought 4,465 shares of Niagen Bioscience, Inc. at $6.81 per share, a transaction worth $30.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,465
Price
$6.81
Total value
$30.4K
InsiderPamir Ozan
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 14, 2025
Filing dateNovember 17, 2025
Shares owned after7,372
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average purchase price for the transaction reported was $6.81, and the range of prices were between $6.7975 and $6.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.